AllRock Bio
Boston
About AllRock Bio
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: allrockbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/allrock-bio-50815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.